(GERN, CRWE, RIGL, DNDN) Stocks in Review by CRWEFinance.com

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) February 24, 2012 -- Geron Corporation (Nasdaq:GERN) announced that John A. Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 11:00 a.m. ET on Tuesday, February 28, at the Citi 2012 Global Health Care Conference in New York City.

Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes.

***********************************************



Crown Equity Holdings Inc. (CRWE)

Crown Equity Holdings Inc. (CRWE.OB) (www.crownequityholdings.com) announced that its subsidiary Crown Tele Services Inc. has entered into a letter of intent with BBN Solutions.

BBN Solutions, located in India, and Crown Tele Services Inc. (www.crownteleservices.com) shall form a 50/50 Joint Venture corporation for the purpose of granting to Crown Tele Services Inc., exclusive rights in the United States to BBN's telecommunications marketing process and services.

Commenting on the Letter of Intent, Kenneth Bosket, President of Crown Tele Services Inc., stated: "This Joint Venture will give both companies a strategic advantage within the communication market.

Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions and is a subsidiary of Crown Equity Holdings Inc. For more information visit www.crownteleservices.com

Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. For more information visit www.crownequityholdings.com.

BBN Solutions doing business as BBN Telecom provides both wholesale and retail global communication, as well as calling cards. For more information visit www.bbntel.net

VoIP (Voice over Internet Protocol) phones comprise of digital signals that can be transmitted without any hassle over any broadband internet connection that further generates with the help of wireless VoIP products to attain communication that is completely clear with mobile correspondence. This better mobility helps in getting important deals and phone calls without bearing any loss.

For more information, please visit their website: http://www.crownequityholdings.com

***********************************************

Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and chief financial officer of Rigel, will participate at two upcoming investor conferences. Details of the events are as follows: Citi 2012 Global Health Care Conference; Date: Monday, February 27 at 1:30 p.m. ET. Location: New York, NY. Presenter - Ryan Maynard 32nd Annual Cowen and Company Health Care Conference; Date: Monday, March 5 at 1:30 p.m. ET. Location: Boston, MA. Presenter - James M. Gower. Both events will be webcast live and can be accessed at www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.

***********************************************

Dendreon Corporation (Nasdaq:DNDN) announced that management will host a conference call on Monday, February 27, 2012, at 9:00 a.m. ET to review fourth quarter and year-end financial results. This conference call was previously scheduled at 4:30 p.m. ET on the same date.

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.


********************************************************************



Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.